Stay updated on Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added to the history, and Revision: v3.3.1 appears in the deletions.
    Difference
    0.0%
    Check dated 2025-12-01T16:59:17.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A new revision label v3.3.1 was added and the previous v3.2.0 label removed. No substantive changes to core content or study information are evident; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T12:17:27.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed the site-wide notice regarding government funding and operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T06:20:44.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Version 113 (2025-05-22) was added to the Record History. This is a routine update to the page's history and does not change the study data or status.
    Difference
    0.0%
    Check dated 2025-11-03T00:58:10.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    7%
    Check dated 2025-10-05T08:56:44.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Updated the page version from v3.0.2 to v3.1.0, indicating a new release with potential changes behind the scenes but no other substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T03:04:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.